Abstract: The present invention relates to compounds that have zinc and/or iron ionophore activity and their use in treating diseases that are modulated by reducing zinc and/or iron.

Abstract: The present invention relates to compounds that have zinc and/or iron ionophore activity and their use in treating diseases that are modulated by reducing zinc and/or iron.

Abstract: The present invention provides heterocyclic compounds of formula (I) that modulate biological metals and to pharmaceutical compositions containing such compounds. The invention particularly relates to compounds that modulate iron and to compounds for the treatment of diseases, particularly neurological diseases such as Parkinson's disease (PD), Alzheimer's disease (AD), Alzheimer-type dementia, Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and multiple system atrophy (MSA).

Abstract: The present invention relates to compounds of the formula I or II: (I) (II) processes for their preparation and their use as pharmaceutical agents or compositions in the treatment, of neurological disorders.

Abstract: The present invention relates to compounds of the formula I or II: (I) (II) processes for their preparation and their use as pharmaceutical agents or compositions in the treatment, of neurological disorders.

Abstract: The present invention provides compounds that modulate biological metals and to pharmaceutical compositions containing such compounds. The invention particularly relates to imidazo[1,5-a]pyridine compounds of formula (I) that modulate iron and are useful for the treatment of diseases, particularly neurological diseases such as Parkinson's disease (PD), Alzheimer's disease (AD), Alzheimer-type dementia, Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and multiple system atrophy (MSA). The compounds of formula (I) being where variables are defined herein.

Abstract: An implantable medical device includes a housing; and a header mounted to the housing, the header including a header core including a bore with an electrical contact located within the bore, wherein the electrical contact includes: a first longitudinally extending arm cantilever mounted within the bore; and a second longitudinally extending arm cantilever mounted within the bore.

Abstract: The present invention relates to compounds of the formula I or II: (I) (II) processes for their preparation and their use as pharmaceutical agents or compositions in the treatment, of neurological disorders.

Abstract: The present invention provides compounds that modulate biological metals and to pharmaceutical compositions containing such compounds. The invention particularly relates to imidazo[1,5-a]pyridine compounds that modulate iron and are useful for the treatment of diseases, particularly neurological diseases such as Parkinson's disease (PD), Alzheimer's disease (AD), Alzheimer-type dementia, Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and multiple system atrophy (MSA).

Abstract: The present invention relates to compounds of the formula I or II: (I) (II) processes for their preparation and their use as pharmaceutical agents or compositions in the treatment, of neurological disorders.

Abstract: A neural stimulation system delivers neural stimulation to a target nerve with control of direction of propagation of evoked neural signals in one or more fiber types of the target nerve using electrode configuration, thereby providing effective therapy while minimizing unintended effects. In various embodiments, mechanical parameters of a multi-polar electrode are determined to provide directed propagation of the neural stimulation by effecting neural conduction block in or near the stimulation site. In various embodiments, the electrode includes a cathode for evoking action potentials and a plurality of anodes for blocking the propagation of the evoked action potentials in specified direction(s) and fiber type(s) while minimizing the formation of virtual cathodes.

Abstract: An implantable medical device includes a housing; and a header mounted to the housing, the header including a header core including a bore with an electrical contact located within the bore, wherein the electrical contact includes: a first longitudinally extending arm cantilever mounted within the bore; and a second longitudinally extending arm cantilever mounted within the bore.

Abstract: The present invention relates to compounds of the formula I or II: (I) (II) processes for their preparation and their use as pharmaceutical agents or compositions in the treatment, of neurological disorders.

Abstract: A neural stimulation system delivers neural stimulation to a target nerve with control of direction of propagation of evoked neural signals in one or more fiber types of the target nerve using electrode configuration, thereby providing effective therapy while minimizing unintended effects. In various embodiments, mechanical parameters of a multi-polar electrode are determined to provide directed propagation of the neural stimulation by effecting neural conduction block in or near the stimulation site. In various embodiments, the electrode includes a cathode for evoking action potentials and a plurality of anodes for blocking the propagation of the evoked action potentials in specified direction(s) and fiber type(s) while minimizing the formation of virtual cathodes.

Abstract: The present invention relates to compounds of the formula I or II: (I) (II) processes for their preparation and their use as pharmaceutical agents or compositions in the treatment, of neurological disorders.

Abstract: Embodiments herein relate to implantable chemical sensors for detecting a physiological analyte and medical devices including the same. In an embodiment, an implantable medical device is included. The implantable medical device can include a chemical sensor configured to detect an ion concentration in a bodily fluid. The chemical sensor can include a sensing element. The sensing element can include an outer barrier layer forming a top, a bottom, and opposed sides of the sensing element and a structural reinforcing element contacting the outer barrier layer. The top of the outer barrier layer of the sensing element can include a polymeric matrix permeable to analytes.

Abstract: The present invention relates to compounds of the formula I or II: (I) (II) processes for their preparation and their use as pharmaceutical agents or compositions in the treatment, of neurological disorders.

Abstract: Various embodiments concern a lead system for anchoring a lead, the lead system comprising a lead and an anchor. The anchor can comprise a ring and a flange extending from the ring. The anchor can be mounted on the lead such that the lead extends through the ring and the flange extends over an electrode of the lead. The lead system can further comprise a tether having a proximal portion and a distal portion. The proximal portion of the tether can attached to the lead while the distal portion of the tether can be attached to a needle. During an implantation procedure, the tether can be cut to remove the needle. The tether can then be attached to the flange. The lead, the anchor, and the tether can form a loop around a section of tissue to anchor the lead to the tissue.

Abstract: An introducer sheath includes an elongated outer sheath and an elongated inner sheath coaxially disposed within the outer sheath. The elongated outer sheath includes an outer sheath wall extending circumferentially about a longitudinal axis of the outer sheath to an extent greater than 180° and less than 360° to define an outer sheath slot. The elongated inner sheath includes an inner sheath wall extending circumferentially about a longitudinal axis of the inner sheath to an extent greater than the difference between 360° and the circumferential extent of the outer sheath wall, and less than 360° to define an inner sheath slot. The inner sheath is rotatable relative to the outer sheath to form an enclosed lumen when the outer and inner sheath slots are not aligned, and to form an open slot along the entire length of the introducer sheath when the outer and inner sheath slots are aligned.

Abstract: Various embodiments concern an implantable lead. The lead can comprise a lead body. At least two conductors can extend within the lead body, such as in respective lumens of the lead body. The lead can comprise at least two electrodes. Each electrode can be connected to a respective one of the at least two conductors. A paddle body can be connected to the lead body. The paddle body can comprise a longitudinal axis that divides the paddle body into left and right sides. The at least two electrodes can be partially embedded within the paddle body. The at least two electrodes can be arrayed along the longitudinal axis. Each electrode can be asymmetric about the longitudinal axis.